Danese S, Dignass A, Matsuoka K, Ferrante M, et al. Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Program. J Crohns Colitis 2024 Jun 13:jjae088. doi: 10.1093.
PMID: 38869019